Real-time enrollment status for this her2+ metastatic breast cancer (mbc) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:59 PM UTC
| NCT Number | NCT06983691 |
| Recruiting Status | Recruiting |
| Condition | HER2+ Metastatic Breast Cancer (MBC) |
| Phase | NA |
| Target Enrollment | 26 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Duke University |
| Last Updated on CT.gov | September 8, 2026 (Sep 8, 2026) |
As of October 12, 2026: Clinical trial NCT06983691 is currently recruiting participants. This na study for her2+ metastatic breast cancer (mbc) is actively seeking new participants at 1 location across the United States. The study is sponsored by Duke University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06983691 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06983691 was last updated Sep 8, 2026 (September 8, 2026). HelloStudys verifies this status automatically.